Single and multiple dose evaluation of a novel MetAP2 inhibitor: Results of a randomized, double‐blind, placebo‐controlled clinical trial

por Malloy, Jaret, Zhuang, Dongliang, Kim, Terri, Inskeep, Phil, Kim, Dennis, Taylor, Kristin
Publicado 2018

Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials

por DeFronzo, Ralph A., Buse, John B., Kim, Terri, Burns, Colleen, Skare, Sharon, Baron, Alain, Fineman, Mark
Publicado 2016

DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks

por Buse, John B., Drucker, Daniel J., Taylor, Kristin L., Kim, Terri, Walsh, Brandon, Hu, Hao, Wilhelm, Ken, Trautmann, Michael, Shen, Larry Z., Porter, Lisa E.
Publicado 2010